Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant).
Conference
Bell, Erica Hlavin, McElroy, Joseph P, Fleming, Jessica et al. (2016). Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant).
. JOURNAL OF CLINICAL ONCOLOGY, 34(15), 10.1200/JCO.2016.34.15_suppl.2016
Bell, Erica Hlavin, McElroy, Joseph P, Fleming, Jessica et al. (2016). Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT plus TMZ vs RT plus nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant).
. JOURNAL OF CLINICAL ONCOLOGY, 34(15), 10.1200/JCO.2016.34.15_suppl.2016